Ginkgo Bioworks Holdings Inc

DNA

Company Profile

  • Business description

    Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

  • Contact

    27 Drydock Avenue
    8th Floor
    BostonMA02210
    USA

    T: +1 877 422-5362

    https://www.ginkgobioworks.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    834

Stocks News & Analysis

stocks

Ask the analyst: Are Qantas shares a value trap?

Qantas’ pandemic woes seem a distant memory. But could the party end sooner than investors think?
stocks

Palantir earnings: Blockbuster growth amid high expectations

We raise our fair value estimate off the back of earnings.
stocks

ResMed earnings: Solid showing from ASX healthcare winner

Strong demand growth and improved profit margins lead to a strong result from the sleep apnea device firm.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,111.1082.300.91%
CAC 407,661.1640.120.53%
DAX 4023,973.66127.590.54%
Dow JONES (US)44,111.7461.90-0.14%
FTSE 1009,160.1717.440.19%
HKSE24,958.3055.770.22%
NASDAQ20,916.55137.03-0.65%
Nikkei 22540,794.86245.320.60%
NZX 50 Index12,880.163.120.02%
S&P 5006,299.1930.75-0.49%
S&P/ASX 2008,843.7073.300.84%
SSE Composite Index3,633.9916.400.45%

Market Movers